The most common form of glucose transporter type I deficiency (Glut1 deficiency, G1D), a metabolic encephalopathy associated with mutations of the SLC2A1 gene, constitutes a form of medication-refractory epilepsy (Pascual and Ronen, 2015). Here, SLC2A1 is linked to encephalopathy due to GLUT1 deficiency.